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The term vasculitis is usually applied to a diverse
group of relatively uncommon diseases, which are
characterized by the development of inflammatory
changes of the arterial wall. These diseases seem to
be of immunological origin but the precise cause and
pathogenesis remain poorly understood.1
Among the systemic vasculitides, systemic rheuma-
toid vasculitis (SRV) is the most common.2 Its acute or
chronic inflammatory changes are often confined to
the wall of small and medium sized arteries,1 causing
Raynaud's phenomenon, periungual infarcts, digital
pad ulcers or gangrene and mesenteric ischaemia or
bowel infarction.
Reported cases of SRV manifestations include
necrotising vasculitis of the gallbladder and the
appendix,3 non-permanent tonic pupil,4 perforation
of the ileum resulting from mesenteric arteritis5 and
acute congestive heart failure as a consequence of
arteritis confined to small myocardial vessels.6
We present a rare case of acute popliteal artery
thrombosis occurring in a young male patient with a
history of deforming sero-negative rheumatoid arth-
ritis. From a search in the literature, this is the first
reported case of critical lower limb ischaemia after
acute popliteal artery thrombosis within the context
of SRV.Please address all correspondence to: A. N. Katsamouris, Associate
Professor of Vascular Surgery, Director, Vascular Surgery, University
of Crete Medical School, University Hospital of Heraklion,
Heraklion, Crete, Greece.
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A 39-year-old man presented with a two-month his-
tory of coolness and cyanosis of the first, second, third
and fourth toes of the right foot. He had also a grad-
ually enlarging, asymptomatic crust of the first toe
and a small skin erosion between the third and fourth
toe of the same foot. The patient was a light smoker
(10 packs/year) with a history of deforming rheuma-
toid arthritis (Fig. 1). His general condition was good
and he was able to work as a technician in a hotel. He
he had been occasionally treated in the past with
biofenac 100 mg twice daily, orally, prednisolone
5 mg once daily, orally, methotrexate 2.5 mg four
times daily, orally and hydroxychloroqinue sulfate
200 mg once daily, orally.Fig. 1. Destructive joint disease in both hands with ulnar deviation
of the fingers.
cense.
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Service and the initial differential diagnosis included
skin mucosis, Buerger's disease and vasculitis. Chest
and right foot X-ray examinations were normal. Blood
analysis and serum biochemical routine was normal
whereas the c-reactive protein (CRP) and erythrocyte
sedimentation rate (ESR) were raized (CRP4 10 and
ESR 160 mm, respectively). Serologic examinations
were within the normal values: IgA: 616, IgE: 2340,
IgM: 112, C3: 151, C4: 16.6, and rheumatoid factor
(RF)520. Additional investigation of antinuclear anti-
bodies (ANA), antineutrophilic cytoplasmic antibo-
dies (ANCA), anti-ds DNA, anti-cardiolipin as well
as anti-b2 glycoproteine antibodies provided negative
results. The coagulation profile was also normal (PT:
12.8, aPTT: 35.5, INR: 1.2, and protein-C: 90%, protein-
S: 80%). Cultures taken from the toe lesions grew
Pseudomonas Aeroginosa.
Musculoskeletal examination disclosed modest
active synovitis in several joints of the hands and
feet, ulnar deviation and no evidence of rheumatoid
nodules.
A few days later the Division of Vascular Surgery
were asked to evaluate the patient. On physical exam-
ination decreased pulses of the right popliteal artery
and absent pulses of the right anterior and posterior
tibial artery were found. The ankle-brachial pressure
index (ABPI) was 0.7 on the right foot and 1.1 on the
left foot. Colour duplex scanning demonstrated a
moderate stenosis (about 50%) of the right popliteal
artery and monophasic waveforms in the tibial
arteries. A subsequent conventional arteriogram con-
firmed the popliteal artery lesion and disclosed occlu-
sion of the distal part of the tibial arteries with the
development of collateral arteries with a `` corkscrew''
type appearance (Figs 2a, b).
Based on these findings, a diagnosis of Buerger's
disease was made. The patient was persuaded to stop
smoking and treatment was started with courses of
iloprost 0.1 mg/1 ml intravenously for six hours daily,
and piperacillin 2 g tid, intravenously, based on the
sensitivity test. He continued taking hydroxychloroqi-
nue and prednisolone at the normal dose. The condi-
tion of the foot after an initial moderate improvement
over the first 12 days of the treatment suddenly dete-
riorated significantly and the patient developed rest
pain associated with a dramatic decrease in the ABPI
(more than 0.4). At that time the patient was trans-
ferred to the Division of Vascular Surgery, and a new
arteriogram showed thrombosis of the entire segment
of the right popliteal artery with arterial reconstitution
at the level of the anterior tibial origin (Fig. 3a).
Consequently catheter-directed thrombolysis was
started immediately via an antegrade right commonEJVES Extra, 2002femoral artery puncture. Four boluses of 5 mg recom-
binant tissue plasminogen activator (r-tPA) each were
given within 20 minutes and thereafter 2.5 mg/h, via
a 5F multi-sidehole catheter (Mewissen, Boston
Scientific, Watertown, MA, U.S.A.) embedded into
the thrombus. Four hours later, satisfactory lysis of
the thrombosed arterial segment was achieved dis-
closing two long tight stenoses, one of which corre-
sponded to the previously moderately stenosed
segment of the popliteal artery (Fig. 3b).
On completion of thrombolysis, unfractionated
heparin-sodium 25 000 I.U over 24 h was administered
as a continuous infusion intravenously for three days,
thereafter replaced by subcutaneous administration of
nadroparine-calcium (Fraxiparine) 0.3 ml twice daily.
Evaluation by the Rheumatology Service raized the
possibility of a thrombotic complication within the
context of SVR.
Therefore, aggressive anti-inflammatory and im-
munosuppressive therapy was started with methyl-
prednizolone (Solu-Medrol) 1 g IV daily and
cyclophosphamide (Endoxan) 1500 mg IV daily.
Over the next few days perfusion of the right lower
leg gradually improved, maintaining an ABPI of 0.6
with an absolute systolic blood pressure in the poster-
ior tibial artery of 80 mmHg. However, the ischemia of
the third and fourth toe had progressed with the
development of gangrene and superimposed infec-
tion. For that reason the patient was subjected to a
right forefoot open amputation and ten days later,
after the infection had subsided, wound closure was
undertaken.
The patient had an uneventful post-operative
period and was discharged home ten days later. Intra-
venous pulses of cyclophosphamide plus methylo-
prednisolone were administered to the patient
every month over the following year. Follow-up with
color duplex scanning, which was carried-out one
month after his discharge from the hospital and
three-monthly thereafter, revealed a re-thrombosis of
the right popliteal artery, but adequate flow was
detected in the tibial arteries. A year after the oper-
ation, he remains in a good general condition with a
well-healed stump and able to walk and drive using a
special prosthesis.
Discussion
SVR is an uncommon but potentially serious compli-
cation of rheumatoid arthritis, which is found in up
to 4±5% of the patients suffering from rheumatoid
arthritis.7 Its overall annual incidence is 12.5/million
(8.5±17.5) with a male to female ratio of 1 : 1.45.2,7
Rheumatoid Vasculitis with Acute Popliteal Artery Thrombosis 5The pathogenesis of SRV is only clear to some
extent.1 However, both immune-complex and cell-
mediated pathogenetic mechanisms have been impli-
cated. The clinical consequences of thrombotic events
and tissue ischemia are not always obvious depending
on the abruptness and duration of the inflammatory
process and the effectiveness of collateral circulation.1
Histologically, two main types are documented in
SRV8:
(1) Fibrinoid vasculitis similar to periarteritis nodosa
with characteristic areas of narrowing and micro-
aneurysms, and
(2) Endarteritis obliterans type.
These lesions are often restricted to small or
medium sized arteries producing systemic and local,
mainly dermal, manifestations or complications from
catastrophic arterial occlusion in vital organs.1
There is considerable confusion regarding the need
for accurate differential diagnosis between the various
vasculitides. This is because of the existing overlap in
clinical and laboratory findings.9 The arteriographic
appearance of rheumatoid arteritis for instance may
be identical to that seen in patients with scleroderma,
Buerger's disease, CREST syndrome, and SLE.10
In addition, the relevant clinical as well as serologic
findings are not often so specific. The Chapel Hill
Consensus Conference held in 1993/94 identified
and published definitions for the nomenclature
of systemic vasculitides based on clinical features.
However, these are not universally accepted.
In the diagnosis of SRV various clinical, angio-
graphic, histopathologic and laboratory criteria have
been proposed, which are not definitive. Clinical
sings, such as rheumatic nodules, hepatomegaly, skin
atrophy, ankle deformity and sings of cutaneous vas-
culitis (palpable purpura, punched-out skin
ulcerations), or signs of systemic vasculitis (digital
pulp lesions, mononeuritis multiplex, glomerulone-
phritis) may be present in patients suffering from
SRV.11 High titres of rheumatoid factor and circulating
immune complexes (C1q-BT), increased concentra-
tions of CRP, hypocomplementemia, hypoalbunemia,
decreased choline esterase activity, elevated alkaline
phosphatase activity and leukocytosis are also
characteristic laboratory features of SRV.1,7,11
The more common angiographic findings of SRV
consist of involvement of small and medium-sized
vessels, segmental occlusive lesions, microaneurysms,
and collateralization around areas of occlusion
with normal proximal arteries. Finally, the histopa-
thological examination of the affected tissue may
show one of the two characteristic types mentioned
previously, but often is inconclusive or unspecific.12Previous reported studies have shown that leg
ulcers may be found in approximately 10% of patients
with rheumatoid arthritis.13 Additionally, a recent
study14 showed that concurrent chronic arterial and
venous disease can be found in about half of the
patients who suffer from rheumatoid arthritis and
experience leg ulceration. Intravenous administration
of high dose immunosuppressive treatment may
achieve alleviation of the acute inflammatory process
of SRV.15
In this case, the presumptive diagnosis of Buerger's
disease was made based on the low activity of
rheumatoid arthritis at the time of presentation, the
lack of serologic evidence of rheumatoid vasculitis
(negative RF, high complement levels), the arterio-
graphic features, patient's age, tobacco abuse, and
the lack of a pre-existing history of atherosclerosis or
venous disease.
The coexistence of deforming rheumatoid arthritis
and the improvement of limb perfusion with the
administration of high dose immunosuppressive
treatment led us finally to abandon our initial diagno-
sis. Therefore, besides the absence of a direct causal
relationship due to lack of specific laboratory and
definitive histopathological findings, the acute poplit-
eal artery thrombosis was eventually attributed to a
localised arterial insult from SRV.
Catheter-directed thrombolysis produced tempor-
ary dissolution of thrombus and disclosure of the
arterial lesions, the appearance of which resembled
arteritis. However, thrombolysis failed to maintain
patency via the involved arterial segment as they
re-occluded early after discontinuation of thromboly-
sis despite treatment with low molecular weight hep-
arin at a therapeutic dose. We opted not to proceed
with surgical revascularisation of the limb because of
the potential high risk of graft thrombosis. A conser-
vative approach with high dose immunosuppressive
treatment was chosen, with the aim of alleviating the
acute arterial insult. This achieved improvement in
limb perfusion, allowing local forefoot amputation
with excellent wound healing. Maintenance immuno-
suppressive treatment prevented any relapse of the
disease.
In conclusion, this is to our knowledge the first
reported case of acute popliteal artery thrombosis
causing acute limb ischemia as a consequence of
SRV. Physicians should bear in mind that this entity,
although rare, could potentially cause serious vascular
complications even when clinical features are not
typical. Diagnosis may be difficult and because of
its rarity experience in regard to the management of
vascular complications is limited. In the event of acute
lower limb arterial occlusion, thrombolysis mayEJVES Extra, 2002
6 A. D. Giannoukasachieve temporary arterial patency, disclosing the
characteristics of the arterial damage, which facilitates
the diagnosis. High dose immunosuppressive treat-
ment in our case alleviated the acute systemic insult
resulting in improvement of tissue perfusion and
limb salvage despite the presence of arterial occlusion.
Minor amputation was required because of toe
gangrene, but good would healing was achieved.
Maintenance immunosuppressive treatment may
prevent recurrence of the disease.
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